SCHEMBL932259

SCHEMBL932259

COCCNc1ccc(F)cc1[N+](=O)[O-]

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.68
HCAR3 P49019 1/20 0.66
MAPT P10636 8/20 0.62
ALDH1A1 P00352 4/20 0.62
RAB9A P51151 2/20 0.60
PTGER4 P35408 1/20 0.60
POLB P06746 3/20 0.58
MEN1 O00255 1/20 0.58
KMT2A Q03164 1/20 0.58
BCHE P06276 1/20 0.50
ACHE P22303 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
SMN1; SMN2 Q16637 2/20 0.48
NPC1 O15118 1/20 0.48
HTT P42858 1/20 0.47
KAT2B Q92831 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1420938 0.91 HCAR3 (0.58) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL31121972 0.89 LMNA (0.68) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL17845647 0.89 LMNA (0.68) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL20797635 0.86 KMT2A (0.53) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL20797617 0.85 MAPT (0.50) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL2716434 0.84 LMNA (0.70) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL4086159 0.84 HCAR3 (0.63) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL15774731 0.83 LMNA (0.68) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL15595336 0.83 LMNA (0.68) LMNAHCAR3MAPTALDH1A1RAB9A
SCHEMBL8115811 0.82 MAPT (0.71) LMNAHCAR3MAPTALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2448932-B1 NOVEL 6-MORPHOLIN-4-YL-PYRIMIDIN-4-(3H)-ONE DERIVATIVES, AND THE PHARMACEUTICAL PREPARATION THEREOF AS AKT(PKB) PHOSPHORYLATION INHIBITORS SANOFI SA (FR) 2014-03-05 EP disclosed
EP-2448932-B1 NOVEL 6-MORPHOLIN-4-YL-PYRIMIDIN-4-(3H)-ONE DERIVATIVES, AND THE PHARMACEUTICAL PREPARATION THEREOF AS AKT(PKB) PHOSPHORYLATION INHIBITORS SANOFI SA (FR) 2014-03-05 EP disclosed
US-8507483-B2 1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation SANOFI (FR) 2013-08-13 US disclosed
US-8507483-B2 1H-pyrimidin-2-one derivatives, preparation thereof and pharmaceutical use thereof as inhibitors of AKT (PKB) phosphorylation SANOFI (FR) 2013-08-13 US disclosed
EP-2448932-A1 NOVEL 6-MORPHOLIN-4-YL-PYRIMIDIN-4-(3H)-ONE DERIVATIVES, AND THE PHARMACEUTICAL PREPARATION THEREOF AS AKT(PKB) PHOSPHORYLATION INHIBITORS SANOFI (FR) 2012-05-09 EP disclosed
WO-2011001115-A1 NOVEL 6-MORPHOLIN-4-YL-PYRIMIDIN-4-(3H)-ONE DERIVATIVES, AND THE PHARMACEUTICAL PREPARATION THEREOF AS AKT(PKB) PHOSPHORYLATION INHIBITORS SANOFI-AVENTIS (FR) 2011-01-06 WO disclosed
WO-2011001115-A1 NOVEL 6-MORPHOLIN-4-YL-PYRIMIDIN-4-(3H)-ONE DERIVATIVES, AND THE PHARMACEUTICAL PREPARATION THEREOF AS AKT(PKB) PHOSPHORYLATION INHIBITORS SANOFI-AVENTIS (FR) 2011-01-06 WO disclosed